Cns Pharmaceuticals Inc (CNSP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 6,461 | 6,973 | 1,492 | 815 | 549 |
| Receivables | 883 | N/A | N/A | N/A | N/A |
| Other current assets | 21 | 27 | 17 | 0 | 203 |
| TOTAL | $8,659 | $7,388 | $2,145 | $1,601 | $1,591 |
| Non-Current Assets | |||||
| PPE Net | 6 | 3 | 4 | 4 | 5 |
| Other Non-Current Assets | 36 | 18 | 320 | 55 | 105 |
| TOTAL | $42 | $21 | $324 | $60 | $110 |
| Total Assets | $8,701 | $7,409 | $2,469 | $1,661 | $1,701 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,198 | 4,026 | 6,640 | 5,878 | 5,832 |
| TOTAL | $2,524 | $4,057 | $6,763 | $6,091 | $6,133 |
| Non-Current Liabilities | |||||
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $2,524 | $4,057 | $6,763 | $6,091 | $6,133 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 245 | 96 | 54 | 0 | 0 |
| Common Shares | 0 | 33 | 1 | 11 | 0 |
| Retained earnings | -84,425 | -81,248 | -75,642 | -73,112 | -69,567 |
| TOTAL | $6,177 | $3,352 | $-4,294 | $-4,431 | $-4,432 |
| Total Liabilities And Equity | $8,701 | $7,409 | $2,469 | $1,661 | $1,701 |